BCL10 anticorps (Center)

N° du produit ABIN7834771

L’anticorps anti-BCL10 Monoclonal Souris est utilisé pour la détection de BCL10 dans des échantillons de Humain. Il a été validé pour WB, IHC et FACS.

Aperçu rapide pour BCL10 anticorps (Center) (ABIN7834771)

Antigène: BCL10 (B-Cell CLL/lymphoma 10 (BCL10))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp BCL10 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)

Classe de qualité: KO Validated, KD Validated

Détail du produit anti-BCL10 anticorps

Épitope: Center

Fonction: Mouse monoclonal antibody to BCL10

Specificité: Recognizes endogenous levels of BCL10 protein.

Purification: This antibody is purified through a protein G column.

Immunogène: KLH-conjugated synthetic peptide encompassing a sequence within the center region of human BCL10. The exact sequence is proprietary.

Information d'application

Indications d'application: WB (1/500 - 1/1000), IH (1/50 - 1/200), FC (1/10 - 1/50)

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid in PBS, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

Détails sur BCL10

Antigène: BCL10 (B-Cell CLL/lymphoma 10 (BCL10))

Autre désignation: BCL10

Sujet: CIPER, CLAP, B-cell lymphoma/leukemia 10, B-cell CLL/lymphoma 10, Bcl-10, CARD-containing molecule enhancing NF-kappa-B, CARD-like apoptotic protein, hCLAP, CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER, Cellular homolog of vCARMEN, cCARMEN, Cellular-E10, c-E10, Mammalian CARD-containing adapter molecule E10, mE10

ID gène: 8915

UniProt: O95999

Pathways: TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins